Standigm
Established as a pioneer in AI-driven drug discovery, Standigm utilizes cutting-edge artificial intelligence to streamline the development of pharmaceuticals. With a robust AI platform that includes biology and chemistry components, Standigm accelerates the discovery of novel drug targets and molecular designs, aiming to revolutionize patient care globally.
- Webinar
AI meets chemistry: Standigm’s breakthrough with Synthia Retrosynthesis Software
Discover how Standigm’s use of Synthia can accelerate AI-driven drug discovery